Researchers evaluated the impact of upadacitinib on early pain control among patients with axial spondyloarthritis.

The approval was supported by data from 3 double-blind, placebo-controlled trials that included a total of 1474 patients who met the 2016 ACR criteria for diagnosis of fibromyalgia.

Researchers assessed how obesity influences spinal radiographic features among patients with metabolic syndrome.